Category: Pay for Delay

Supreme Court Holds That “Pay for Delay” Pharmaceutical Patent Settlements May Violate the Antitrust Laws

by healthlawblog | Jun 24, 2013

By James M. BurnsOn June 17, the United States Supreme Court issued its highly-anticipated decision in FTC v. Actavis Inc., a case with significant implications for patent law, antitrust law and healthcare law. The case...

FTC Issues New Report on “Pay for Delay” Patent Settlements

by healthlawblog | Jan 31, 2013

By James M. BurnsAccording to a new report by the Federal Trade Commission, brand-name pharmaceutical companies increased their use of “pay for delay” patent settlements last year (October 2011 – September 2012). Of the...

Newsletter Subscription

<a href="https://marketing.dickinson-wright.com/s/f85515f7bd70da1e2e6dd0d85f2ab1a7b0cb3fb9">View Survey</a>

Disclaimer

The Health Law Blog is published by Dickinson Wright PLLC to inform the public of important developments within the firm and practice areas. The content is informational only and does not constitute legal or professional advice. We encourage you to consult a Dickinson Wright attorney if you have specific questions or concerns relating to any of the topics covered in this blog.

Category: Pay for Delay

Supreme Court Holds That “Pay for Delay” Pharmaceutical Patent Settlements May Violate the Antitrust Laws

FTC Issues New Report on “Pay for Delay” Patent Settlements

Newsletter Subscription

Disclaimer

Categories